Tramadol provides modest relief for back pain, but the benefit is smaller than most people expect. A large meta-analysis found that tramadol reduces chronic pain scores by less than 1 point on a standard 0-to-10 scale, which falls below what researchers consider a clinically meaningful difference. It can still be a reasonable option in specific situations, but it’s not a first-line choice for most back pain.
Where Tramadol Fits in Back Pain Treatment
The American College of Physicians places tramadol as a second-line medication for chronic low back pain. That means it’s recommended only after non-drug treatments (like physical therapy, exercise, or heat) have failed and anti-inflammatory drugs like ibuprofen or naproxen haven’t provided enough relief. Tramadol isn’t something you’d typically start with for a new episode of back pain.
This ranking reflects a practical reality: anti-inflammatories tend to work better for the type of inflammation and muscle tension behind most back pain, and they carry fewer risks. Tramadol enters the picture when those options aren’t working or can’t be used safely, such as in people with stomach ulcers or kidney problems that make anti-inflammatories risky.
How Tramadol Works Differently From Other Pain Drugs
Tramadol has a dual mechanism that sets it apart from both standard painkillers and stronger opioids. It weakly activates the same brain receptors that morphine and oxycodone target, but it also blocks the reabsorption of serotonin and norepinephrine, two brain chemicals involved in mood and pain signaling. This second action is similar to how certain antidepressants reduce chronic pain.
Here’s a detail that matters: tramadol itself is relatively inactive. Your liver has to convert it into a more potent form before the opioid component kicks in. How well your body performs that conversion varies widely from person to person based on genetics. Some people metabolize it quickly and feel strong effects, while others barely convert it at all and get little pain relief. This partly explains why tramadol works well for some patients and does almost nothing for others.
How Much Pain Relief to Realistically Expect
When researchers pooled the results of multiple studies on tramadol for chronic pain, the average reduction was 0.93 points on a 10-point pain scale compared to a placebo. The threshold for what counts as a clinically important difference is 1.0 point, meaning the average benefit fell just short. Some individuals experience more relief than the average suggests, but as a group effect, it’s modest.
For context, that’s roughly the difference between rating your pain a 6 and rating it a 5. Enough to notice, perhaps, but not transformative. This is one reason guidelines reserve tramadol for situations where other approaches have already been tried.
Risks That May Outweigh the Benefits
Tramadol’s side effect profile is more complex than many patients realize. Common effects include nausea, dizziness, constipation, and drowsiness. But several less obvious risks deserve attention.
Seizures: Tramadol lowers the seizure threshold, especially at higher doses. This risk increases significantly if you’re also taking antidepressants, antipsychotics, or other medications that affect brain excitability. Anyone with a history of seizures or epilepsy should generally avoid tramadol.
Serotonin syndrome: Because tramadol boosts serotonin levels, combining it with antidepressants (SSRIs, SNRIs, tricyclics, or MAOIs) can trigger serotonin syndrome, a potentially dangerous condition marked by agitation, fever, rapid heart rate, muscle twitching, and excessive sweating. This is particularly relevant for back pain patients, since chronic pain and depression frequently overlap, and many people with ongoing back pain are already taking an antidepressant. St. John’s wort, a common herbal supplement, also raises the risk.
Respiratory depression: Like all opioids, tramadol can slow breathing. The risk is highest when starting the medication, after a dose increase, or when combined with benzodiazepines (anti-anxiety medications like alprazolam or lorazepam), alcohol, or other sedating drugs.
Adrenal insufficiency: With use lasting longer than a month, tramadol can suppress your adrenal glands, leading to fatigue, weakness, and low blood pressure. This is a lesser-known effect that often goes unrecognized.
The Dependency Question
Tramadol has long been considered less addictive than stronger opioids. The DEA classifies it as a Schedule IV controlled substance, two levels below oxycodone and hydrocodone. But a large study from the Mayo Clinic examining nearly 445,000 surgical patients tells a more complicated story.
Researchers tracked how many patients continued refilling opioid prescriptions long after their surgical pain should have resolved. About 7% had refills 90 to 180 days after surgery, 1% continued at 180 to 270 days, and 0.5% became long-term users. Patients who received tramadol were just as likely to continue using opioids past the expected recovery window as those who received hydrocodone or oxycodone. The study’s conclusion was blunt: the data doesn’t support the idea that tramadol is less habit-forming than other opioids.
Physical dependence can develop with regular use, meaning your body adapts to the drug and stopping abruptly causes withdrawal symptoms. This is distinct from addiction but still creates a real obstacle to discontinuing the medication.
Special Considerations for Older Adults
Adults over 75 face a lower maximum dose ceiling of 300 mg per day, compared to 400 mg for younger adults. This reflects slower metabolism, greater sensitivity to sedation, and a higher risk of falls. The dizziness and drowsiness tramadol causes can be especially dangerous for older adults who already have balance issues or take other medications that cause sedation.
Older adults are also more likely to be on multiple medications, which increases the chance of dangerous interactions. The combination of tramadol with benzodiazepines, which are commonly prescribed for sleep and anxiety in this age group, is particularly concerning due to the risk of severe sedation and respiratory depression.
Who Might Still Benefit
Tramadol makes the most sense for people with chronic low back pain who have genuinely exhausted non-drug approaches and can’t tolerate or haven’t responded to anti-inflammatory medications. It may also be reasonable as a short-term bridge during a pain flare when the goal is to stay functional while other treatments take effect.
You’re a better candidate if you’re not taking antidepressants or anti-anxiety medications, don’t have a history of seizures, and don’t have a personal or family history of substance use problems. The starting dose is typically low, 25 mg once daily, and is gradually increased only if needed. Keeping the dose and duration as low as possible reduces most of the risks described above.
For many people with back pain, though, the combination of physical therapy, anti-inflammatory medications, and lifestyle changes like regular movement and weight management will provide equal or better relief without tramadol’s risks. The evidence consistently shows that tramadol’s average pain reduction is real but small, and its safety concerns are real and not small.